MAPK10 and Mental deterioration: Another rationale for predicting that neuronal cell death will decrease in the brains of AD patients when JNK3 is inhibited is that neuronal cell death and cognitive decline were also reduced in a JNK3 knock-out FAD mouse model [15] (see Figure 2).